posted on 2003-09-23, 00:00authored byAlexander R. Dunn, Ivan J. Dmochowski, Jay R. Winkler, Harry B. Gray
We report the synthesis and characterization of Ru-diimine complexes designed to bind to
cytochrome P450cam (CYP101). The sensitizer core has the structure [Ru(L2)L‘]2+, where L‘ is a
perfluorinated biphenyl bridge (F8bp) connecting 4,4‘-dimethylbipyridine to an enzyme substrate (adamantane, F8bp-Ad), a heme ligand (imidazole, F8bp-Im), or F (F9bp). The electron-transfer (ET) driving force
(−ΔG°) is varied by replacing the ancillary 2,2‘-bipyridine ligands with 4,4‘,5,5‘-tetramethylbipyridine (tmRu).
The four complexes all bind P450cam tightly: Ru−F8bp-Ad (1, Kd = 0.077 μM); Ru−F8bp-Im (2, Kd = 3.7
μM); tmRu−F9bp (3, Kd = 2.1 μM); and tmRu−F8bp-Im (4, Kd = 0.48 μM). Binding is predominantly driven
by hydrophobic interactions between the Ru-diimine wires and the substrate access channel. With Ru−F8bp wires, redox reactions can be triggered on the nanosecond time scale. Ru-wire 2, which ligates the
heme iron, shows a small amount of transient heme photoreduction (ca. 30%), whereas the transient
photoreduction yield for 4 is 76%. Forward ET with 4 occurs in roughly 40 ns (kf = 2.8 × 107 s-1), and back
ET (FeII → RuIII, kb ≈ 1.7 × 108 s-1) is near the coupling-limited rate (kmax). Direct photoreduction was not
observed for 1 or 3. The large variation in ET rates among the Ru-diimine:P450 conjugates strongly supports
a through-bond model of Ru−heme electronic coupling.